Antipneumococcal seroprevalence and pneumococcal carriage during a meningococcal epidemic in Burkina Faso, 2006. (Q42239180)

19 October 2017

title

Antipneumococcal seroprevalence and pneumococcal carriage during a meningococcal epidemic in Burkina Faso, 2006. (English)

1 reference

19 October 2017

0 references

0 references

Lassana Sangaré

1 reference

19 October 2017

Bradford D Gessner

1 reference

19 October 2017

Seydou Yaro

1 reference

19 October 2017

Berthe-Marie Njanpop-Lafourcade

1 reference

19 October 2017

Aly Drabo

1 reference

19 October 2017

Régina S Idohou

1 reference

19 October 2017

Sita S Kroman

1 reference

19 October 2017

Oumarou Sanou

1 reference

19 October 2017

Yves Traoré

1 reference

19 October 2017

Serge P Diagbouga

1 reference

19 October 2017

Jean-Louis Koeck

1 reference

19 October 2017

Raymond Borrow

1 reference

19 October 2017

Judith E Mueller

1 reference

19 October 2017

language of work or name

English

0 references

publication date

25 November 2013

1 reference

Journal of Infectious Diseases

19 October 2017

published in

1 reference

19 October 2017

volume

209

1 reference

19 October 2017

1 reference

19 October 2017

page(s)

1241-1250

1 reference

Environmental risk and meningitis epidemics in Africa

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT641

Manson Lecture. Meningococcal meningitis in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT641

Pneumococci in the African meningitis belt: meningitis incidence and carriage prevalence in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT641

African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT641

Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT641

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT641

Study of a localized meningococcal meningitis epidemic in Burkina Faso: incidence, carriage, and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT641

Development and validation of a nonaplex assay for the simultaneous quantitation of antibodies to nine Streptococcus pneumoniae serotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT641

Simple, rapid latex agglutination test for serotyping of pneumococci (Pneumotest-Latex).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT641

Nucleotide sequence and expression of the pneumococcal autolysin gene from its own promoter in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT641

Neisseria meningitidis serogroups W135 and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT641

Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vacc

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT641

Epidemiology of invasive pneumococcal disease in southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT641

Invasive pneumococcal disease in Dallas County, Texas: results from population-based surveillance in 1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT641

Invasive pneumococcal infections in Denmark from 1995 to 1999: epidemiology, serotypes, and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT641

Seroprevalence of IgG antibodies against 13 vaccine Streptococcus pneumoniae serotypes in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT641

Seroprevalence of bactericidal, specific IgG antibodies and incidence of meningitis due to group A Neisseria meningitidis by age in Burkina Faso 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT641

The fundamental link between pneumococcal carriage and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT641

Application of high-resolution n.m.r. spectroscopy to the elucidation of the structure of the specific capsular polysaccharide of Streptococcus pneumoniae type 7F.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT641

The Neisseria meningitidis serogroup A capsular polysaccharide O-3 and O-4 acetyltransferase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT641

Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian infants: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT641

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT641

Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The Gambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT641

Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT641

Report from a WHO working group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT641

21 January 2018

Identifiers

DOI

10.1093/INFDIS/JIT641

1 reference

19 October 2017

1 reference